Panza N - Search Results

1

High serum thyroglobulin levels. Diagnostic indicators in patients with metastases from unknown primary sites.

Panza N, Lombardi G, De Rosa M, Pacilio G, Lapenta L, Salvatore M. Panza N, et al. Cancer. 1987 Nov 1;60(9):2233-6. doi: 10.1002/1097-0142(19871101)60:9<2233::aid-cncr2820600922>3.0.co;2-y. Cancer. 1987. PMID: 3440233

2

Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.

Panza N, Pacilio G, Campanella L, Peluso G, Battista C, Amoriello A, Utech W, Vacca C, Lombardi G. Panza N, et al. Cancer. 1988 Jan 1;61(1):76-83. doi: 10.1002/1097-0142(19880101)61:1<76::aid-cncr2820610113>3.0.co;2-g. Cancer. 1988. PMID: 2446734

3

(131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.

Lupoli G, Lombardi G, Panza N, Biondi B, Pacilio G, Lastoria S, Salvatore M. Lupoli G, et al. Among authors: panza n. Med Oncol Tumor Pharmacother. 1991;8(1):7-13. doi: 10.1007/BF02988565. Med Oncol Tumor Pharmacother. 1991. PMID: 2041383

4

Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.

Esposito G, Panza N, Mansi L, De Matteis A, D'Aiuto G, Labonia V, Riccardi F, Pacilio G, Salvatore M. Esposito G, et al. Among authors: panza n. J Nucl Med Allied Sci. 1990 Apr-Jun;34(2):88-93. J Nucl Med Allied Sci. 1990. PMID: 2246676

5

A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report.

Lastoria S, D'Amico P, Mansi L, Giordano GG, Rossiello R, Schlom J, Pace E, Panza N, Pacilio G, Salvatore M. Lastoria S, et al. Among authors: panza n. Nucl Med Commun. 1988 May;9(5):347-56. doi: 10.1097/00006231-198805000-00003. Nucl Med Commun. 1988. PMID: 2842708

6

Usefulness of serum thyroglobulin at replacement withdrawal after thyroidectomy for differentiated thyroid cancer.

Panza N, De Rosa M, Lombardi G, Salvatore M. Panza N, et al. J Nucl Med. 1985 Mar;26(3):316-7. J Nucl Med. 1985. PMID: 3973744 No abstract available.

7

Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma.

Panza N, De Rosa M, Lombardi G, Salvatore M. Panza N, et al. J Endocrinol Invest. 1985 Aug;8(4):357-8. doi: 10.1007/BF03348513. J Endocrinol Invest. 1985. PMID: 4067207

8

Serum thyroglobulin in patients with early thyroid cancer who have residual thyroid after total thyroidectomy.

Panza N, De Rosa M, Lombardi G, Salvatore M. Panza N, et al. Lancet. 1984 Feb 18;1(8373):398. doi: 10.1016/s0140-6736(84)90452-5. Lancet. 1984. PMID: 6141460 No abstract available.

9

Follicular thyroid carcinoma and mediastinal goiter in a case of situs inversus viscerum.

Panza N, Mansi L, Pacilio C, Lombardi G. Panza N, et al. Q J Nucl Med. 1995 Jun;39(2):116-8. Q J Nucl Med. 1995. PMID: 8574804

10

131I total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.

Panza N, Lombardi G, Minozzi M, Salvatore M, Claudio F, Mariano A, Macchia V. Panza N, et al. J Nucl Med Allied Sci. 1984 Jan-Mar;28(1):9-12. J Nucl Med Allied Sci. 1984. PMID: 6481470 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters